Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.

Novartis CEO Vas Narasimhan answers questions about COVID-19.

How much do you know about eyes? Learn more about the fastest muscle in the human body.

Inspired by her mother, Vicky Qi leads drug discovery teams.

Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.

Yan Zhao talks about how her team in China responded to an emerging public health crisis.

How Shannon Campbell, Senior Vice President & Franchise Head at Novartis Oncology, came into her current role and leadership position.

Make smart decisions about your research projects.